"IMAGING NEUROINFLAMMATION IN MILD COGNITIVE IMPAIRMENT USING A NOVEL TRANSLOCATOR PROTEIN 18KDA (TSPO) PET RADIOLIGAND: [18F] FEPPA."
- Registry ID
- CAMHPET-CTA 78
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- CENTRE FOR ADDICTION AND MENTAL HEALTH
- Start date
- 2015-11-01
- Last update
- 2013-06-13
Conditions
- COGNITIVE IMPAIRMENT
- NEUROINFLAMMATION
Related clinical trials
- A RANDOMIZED, PARALLEL GROUP, PLACEBO-CONTROLLED, DOUBLE-BLIND, LONGITUDINAL, SINGLE TREATMENT CENTER, PHASE II PROOF-OF-CONCEPT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LUMACAFTOR IN STABLE HEART FAILURE SUBJECTS WITH REDUCED EJECTION FRACTION (HFREF).
- COGNITION WITH VERICIGUAT EVALUATION IN HEART FAILURE
- DOES PSILOCYBIN CHANGE SYNAPTIC VESICULAR DENSITY IN THE BRAINS OF PATIENTS WITH AMNESTIC MILD COGNITIVE IMPAIRMENT
- SOLRIAMFETOL'S EFFECT ON COGNITIVE HEALTH IN APNEA PARTICIPANTS DURING A RANDOMIZED PLACEBO-CONTROLLED STUDY (SHARP): A 5-WEEK DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSSOVER, MULTICENTER STUDY OF SOLRIAMFETOL IN IMPROVING COGNITIVE FUNCTION
- ADJUNCTIVE SEMAGLUTIDE FOR THE TREATMENT OF COGNITIVE DYSFUNCTION IN MAJOR DEPRESSIVE DISORDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
- SYNCHRONIZING EXERCISES, REMEDIES IN GAIT AND COGNITION (SYNERGIC). A RANDOMIZED DOUBLE BLIND TRIAL.
View on source registry